Iron Isomaltoside

USP

• Rapid iron replenishment
•  Low side effects
• Rapid iron replenishment
• Low side effects
• Suitable for IV administration
• Effective for CKD patients
• Reduced risk of hypophosphatemia

Description:

Iron Isomaltoside is a complex compound composed of iron and isomaltose, a disaccharide. It presents as a brownish-red powder with a slightly sweet taste and a characteristic odor. The compound is hygroscopic, meaning it absorbs moisture from the air. Its texture is fine and slightly gritty. Chemically, iron isomaltoside consists of iron ions (Fe2+ or Fe3+) bound to the isomaltose molecule through coordination bonds. The exact ratio of iron to isomaltose can vary depending on the preparation method. The compound is highly soluble in water and forms a clear, reddish-brown solution. Iron isomaltoside is a stable compound under normal conditions, but it can be decomposed by strong acids or oxidizing agents. As a premier manufacturer of pharmaceutical ingredients, WBCIL adheres to rigorous quality standards (GMP and ISO certified), ensuring every batch of iron isomaltoside meets the highest purity, potency, and safety benchmarks. Our decades of experience, dating back to 1962, have cultivated a proven track record of delivering consistent, reliable products that exceed industry expectations.

Applications

Inflammatory Bowel Disease (IBD)-Related Anemia

• Effectively treats iron deficiency anemia in adult IBD patients
• Addresses malabsorption issues common in Crohn's disease and ulcerative colitis
• Helps improve quality of life and reduces fatigue in IBD patients

Gynecological Disorders

• Manages iron deficiency in women with heavy menstrual bleeding (menorrhagia)
• Supports iron levels in patients with uterine fibroids
• Helps prevent anemia in women with chronic gynecological blood loss

Post-Surgery Recovery

• Accelerates hemoglobin recovery after major surgical procedures
• Reduces the need for blood transfusions in the post-operative period
• Supports overall healing and recovery by addressing iron deficiency

Chronic Kidney Disease (CKD)

• Treats iron deficiency anemia in non-dialysis CKD patients
• Helps maintain optimal hemoglobin levels in pre-dialysis stages
• Improves quality of life and reduces cardiovascular risks in CKD patients

Hemodialysis Patients

• Manages chronic iron deficiency in patients undergoing regular hemodialysis
• Supports erythropoiesis-stimulating agent (ESA) therapy
• Helps reduce ESA dosage requirements and associated costs

Additional Applications:

• Pregnancy-related iron deficiency anemia
• Chemotherapy-induced anemia in cancer patients
• Chronic heart failure-associated iron deficiency